[go: up one dir, main page]

PE20142296A1 - Uso de cascaras de palta para obtener insaponificables de palta enriquecidos en hidrocarburos alifaticos saturados y en esteroles - Google Patents

Uso de cascaras de palta para obtener insaponificables de palta enriquecidos en hidrocarburos alifaticos saturados y en esteroles

Info

Publication number
PE20142296A1
PE20142296A1 PE2014001102A PE2014001102A PE20142296A1 PE 20142296 A1 PE20142296 A1 PE 20142296A1 PE 2014001102 A PE2014001102 A PE 2014001102A PE 2014001102 A PE2014001102 A PE 2014001102A PE 20142296 A1 PE20142296 A1 PE 20142296A1
Authority
PE
Peru
Prior art keywords
avocado
sterols
shells
aliphatic hydrocarbons
saturated aliphatic
Prior art date
Application number
PE2014001102A
Other languages
English (en)
Inventor
Philippe Msika
Jacques Legrand
Sebastien Garnier
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of PE20142296A1 publication Critical patent/PE20142296A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/06—Production of fats or fatty oils from raw materials by pressing
    • C11B1/08—Production of fats or fatty oils from raw materials by pressing by hot pressing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/02—Pretreatment
    • C11B1/04—Pretreatment of vegetable raw material
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/06—Production of fats or fatty oils from raw materials by pressing
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

REFERIDO A UN PROCESO PARA OBTENER INSAPONIFICABLE DE PALTA ENRIQUECIDO EN HIDROCARBUROS ALIFATICOS SATURADOS Y EN ESTEROLES A PARTIR DE CASCARAS DE PALTAS, DONDE DICHAS CASCARAS DE PALTA REPRESENTAN DEL 5 AL 50% EN PESO EN RELACION CON EL PESO TOTAL DE LAS PALTAS UTILIZADAS, DONDE EL INSAPONIFICABLE CONTIENE UN 0.2% DE HIDROCARBUROS ALIFATICOS SATURADOS EN PESO Y UN 1% DE ESTEROLES EN PESO, EN RELACION CON EL PESO TOTAL DEL INSAPONIFICABLE Y EN DONDE LOS ESTEROLES SON SELECCIONADOS DEL GRUPO QUE COMPRENDE BETA-SITOSTEROL, CAMPESTEROL, ENTRE OTROS. DICHO INSAPONIFICABLE DE PALTA TIENE USO COMO FARMACO PARA LA PREVENCION Y EL TRATAMIENTO DE TRASTORNOS DE LOS TEJIDOS CONJUNTIVOS TALES COMO ARTROSIS, PATOLOGIAS ARTICULARES TALES COMO REUMATISMO O ENFERMEDADES PERIODICAMENTE TALES COMO GINGIVITIS O PERIODONTITIS.
PE2014001102A 2012-01-13 2013-01-14 Uso de cascaras de palta para obtener insaponificables de palta enriquecidos en hidrocarburos alifaticos saturados y en esteroles PE20142296A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1250367A FR2985665B1 (fr) 2012-01-13 2012-01-13 Utilisation de peau d'avocat pour obtenir un insaponifiable d'avocat enrichi en hydrocarbures aliphatiques satures et en sterols

Publications (1)

Publication Number Publication Date
PE20142296A1 true PE20142296A1 (es) 2015-01-23

Family

ID=38572710

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014001102A PE20142296A1 (es) 2012-01-13 2013-01-14 Uso de cascaras de palta para obtener insaponificables de palta enriquecidos en hidrocarburos alifaticos saturados y en esteroles

Country Status (19)

Country Link
US (1) US9439938B2 (es)
EP (1) EP2802336B1 (es)
KR (1) KR102115042B1 (es)
CN (2) CN104168906B (es)
AR (1) AR089705A1 (es)
AU (1) AU2013208884B2 (es)
BR (1) BR112014017083B1 (es)
CA (1) CA2863494C (es)
CL (1) CL2014001833A1 (es)
ES (1) ES2864598T3 (es)
FR (1) FR2985665B1 (es)
IL (1) IL233586A0 (es)
MX (1) MX358316B (es)
PE (1) PE20142296A1 (es)
PL (1) PL2802336T3 (es)
RU (1) RU2632111C2 (es)
TW (1) TWI592163B (es)
WO (1) WO2013104793A1 (es)
ZA (1) ZA201405771B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6360118B2 (ja) * 2016-09-20 2018-07-18 本田技研工業株式会社 剥離装置及び剥離ステーション
FR3086508B1 (fr) 2018-09-27 2021-10-08 Expanscience Lab Procede de preparation d'avocats deshydrates par sechage micro-ondes
CN113046170B (zh) * 2021-03-26 2022-03-11 大连奥川生物科技有限公司 富含呋喃类脂不皂化物的鳄梨油制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2041594A5 (es) * 1969-04-30 1971-01-29 Expanscience
FR2678632B1 (fr) * 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2798667B1 (fr) * 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
AU2002256554B2 (en) * 2000-12-21 2005-01-20 Aak Denmark A/S A process for preparing vegetable oil fractions rich in non-tocolic, high-melting, unsaponifiable matter
WO2004016106A1 (fr) * 2002-07-29 2004-02-26 Laboratoires Expanscience Procede d'obtention d'un insaponifiable d'avocat riche en lipides furaniques
FR2870742B1 (fr) * 2004-05-28 2008-03-14 Expanscience Laboratoires Sa Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
FR2893628B1 (fr) * 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
JP2012502020A (ja) 2008-09-08 2012-01-26 ポリオル バイオテク エルティーディー． ポリヒドロキシルテート（ｐｏｌｙｈｙｄｒｏｘｙｌｔａｔｅ）脂肪アルコールおよび誘導体を含む化粧品組成物およびその使用
FR2984748B1 (fr) * 2011-12-26 2017-02-10 Expanscience Lab Utilisation d'avocats mous entiers pour obtenir une huile d'avocat riche en insaponifiable

Also Published As

Publication number Publication date
CN110604760A (zh) 2019-12-24
BR112014017083B1 (pt) 2021-02-09
TWI592163B (zh) 2017-07-21
CA2863494C (fr) 2020-06-09
ES2864598T3 (es) 2021-10-14
PL2802336T3 (pl) 2021-08-30
CN104168906A (zh) 2014-11-26
FR2985665B1 (fr) 2015-10-02
TW201332562A (zh) 2013-08-16
EP2802336A1 (fr) 2014-11-19
CA2863494A1 (fr) 2013-07-18
AR089705A1 (es) 2014-09-10
WO2013104793A1 (fr) 2013-07-18
MX2014008535A (es) 2014-08-21
AU2013208884B2 (en) 2017-06-01
EP2802336B1 (fr) 2021-03-03
FR2985665A1 (fr) 2013-07-19
IL233586A0 (en) 2014-08-31
BR112014017083A2 (pt) 2017-06-13
RU2632111C2 (ru) 2017-10-02
AU2013208884A1 (en) 2014-08-28
US9439938B2 (en) 2016-09-13
CL2014001833A1 (es) 2014-10-03
RU2014132231A (ru) 2016-03-10
KR102115042B1 (ko) 2020-05-25
ZA201405771B (en) 2015-11-25
KR20140114425A (ko) 2014-09-26
US20150005273A1 (en) 2015-01-01
MX358316B (es) 2018-08-14
CN104168906B (zh) 2019-10-15

Similar Documents

Publication Publication Date Title
ECSP20018586A (es) Compuestos que contienen pirazolopirimidinona y sus usos
CL2016001579A1 (es) Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen, así como su uso para la preparación de medicamentos.
SV2016005311A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7
MX2021001439A (es) Composiciones y metodos para el tratamiento de la disfuncion de la glandula de meibomio.
ECSP11011517A (es) Compuestos antivirales
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
UY35700A (es) Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística
CU20140081A7 (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
MX2021015631A (es) Moduladores del receptor arilo y metodos para elaborar y usar los mismos.
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
CU20140095A7 (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CR20130671A (es) Antagonistas de trpv4
CO2018005315A2 (es) Moduladores de la interacción de sestrina-gator2 y sus usos
CR20130602A (es) Compuestos novedosos como inhibidores de diacilglicerol aciltransferasa
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
CO2018004581A2 (es) Compuestos de criptoficina y productos conjugados, y sus métodos de preparación
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
NI201500050A (es) Benzamidas
UY34356A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
CO2019012475A2 (es) Composiciones y productos de fragancia novedosos con efectos mejoradores del estado de ánimo
DOP2015000005A (es) Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos
CL2016000677A1 (es) Compuestos derivados de etinilo, moduladores alostericos positivos del receptor mglur4; composicion farmaceutica que los comprende; y su uso en enfermedades del snc, cancer y diabetes tipo 2.
UY37729A (es) NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7
PE20142296A1 (es) Uso de cascaras de palta para obtener insaponificables de palta enriquecidos en hidrocarburos alifaticos saturados y en esteroles

Legal Events

Date Code Title Description
FG Grant, registration